Skip to main navigation

Overview
News & Events
- News Releases
- Events
Stock Information
Financial & Filings
Governance
Responsibility
Investor Resources

News Releases

Year

11 Jun '26

Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders

28 May '26

Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures

26 May '26

Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

13 May '26

Bionano Reports First Quarter 2026 Results and Provides a Business Update

06 May '26

Bionano Announces Leadership Transition

05 May '26

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

29 Apr '26

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

02 Apr '26

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

23 Mar '26

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

17 Mar '26

Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 18

Print Page
Email Alerts
RSS Feeds

Request Email Alerts

© 2026 Bionano Genomics, Inc. All rights reserved. For Research Use Only. Not For Use In Diagnostic Procedures. | Legal Notice | Privacy Policy